Avoiding colectomy during surgical management of fulminant clostridium difficile colitis

Surgical Infections

Volumn 11, Issue 3, 2010, Pages 299-305

  Olivas, Andrea D ^a   Umanskiy, Konstantin ^a   Zuckerbraun, Brian ^b   Alverdy, John C ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEPHALOSPORIN; CLINDAMYCIN; METRONIDAZOLE; VANCOMYCIN;

CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COLON RESECTION; DIARRHEA; HUMAN; ILEOSTOMY; NONHUMAN; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SURGICAL MORTALITY; SURVIVAL; ADULT; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MORTALITY; PEPTOCLOSTRIDIUM DIFFICILE;

ADULT; CLOSTRIDIUM DIFFICILE; COLECTOMY; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS;

EID: 77954914107     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2010.026     Document Type: Review

References (44)

1. Kelly C, Pothoulakis C, LaMont J. Clostridium difficile colitis. N Engl J Med 1994;330:257-261.
2. Settle C, Wilcox M, Fawley W. Prospective study of the risk of Clostridium difficile diarrhea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam. Aliment Pharmacol Ther 1998;12:1217-1223.
3. Wiesen P, Gossum AV, Preiser J. Diarrhoea in the critically ill. Crit Care 2006;12:149-154.
4. Kelly C, Lamont J. Clostridium difficile\More difficult than ever. N Engl J Med 2008;359:1932-1940.
5. Office for National Statistics, UK Statistics Authority. National Statistics UK Available at www.statistics.gov.uk
6. McDonald L, Owings M, Jernigan J. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996 to 2003. Emerg Infect Dis 2006;12:409-415.
7. Pepin J, Valiquette L, Alary M. Clostridium difficile-associated diarrhea in a region of Québec from 1991 to 2003: A changing pattern of disease severity. CMAJ 2004;171:466-472.
8. Pepin J, Vo T, Boutros M, et al. Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum 2009;52:400-405.
9. McDonald L, Kilgore G, Thompson A. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:2433-2441.
10. Hurley B, Nguyen C. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med 2002;162:2177-2184.
11. Reineke J, Tenzer S, Rupnik M. Autocatalytic cleavage of Clostridium difficile toxin B. Nature 2007;446:415-419.
12. Warny M, Pepin J, Fang A. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:1079-1084.
13. MacCannell D, Louie T, Gregson D. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada. J Clin Microbiol 2006;44:2147-2152.
14. Schwan C, Stecher B, Tzivelekidis T, et al. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathogenes 2009;5(10):1-14.
15. Goncalves C, Decre D, Barbut F, Burghoffer B, Petit J. Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile. J Clin Microbiol 2004;42:1933-1939.
16. Barbut F, Decre D, Lalande V. Clinical features of Clostri-dium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 2005;54:181-185.
17. Geric B, Carman R, Rupnik M, et al. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis 2006;193:1143-1150.
18. Kelly C, LaMont J. Clostridium difficile infection. Annu Rev Med 1998;49:375-390.
19. Clabots C, Johnson S, Olson M. Acquisition of Clostridium difficile by hospitalized patients: Evidence for colonized new admissions as a source of infection. J Infect Dis 1992;166:561-567.
20. Delmée M, Van Broeck J, Simon A, et al. Laboratory diagnosis of Clostridium difficile-associated diarrhoea: A plea for culture. J Med Microbiol 2005;54:187-191.
21. Dallal R, Harbrecht B, Boujoukas A, et al. Fulminant Clos-tridium difficile: An underappreciated and increasing cause of death and complications. Ann Surg 2002;235:363-372.
22. Lamontagne F, Labbe A, Haeck O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg 2007;245:267-272.
23. Byrn J, Maun D, Gingold D, et al. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg 2008;143:150-154.
24. Ash L, Baker M, O'Malley C Jr. Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: Prevalence and significance of findings. AJR Am J Roent-genol 2006;186:1393-1400.
25. Kirkpatrick I, Greenberg H. Evaluating the CT diagnosis of Clostridium difficile colitis: Should CT guide therapy? AJR Am J Roentgenol 2001;176:635-639.
26. Longo W, Mazuski J, Virgo K, et al. Outcome after co-lectomy for Clostridium difficile colits. Dis Colon Rectum 2004;47:1620-1626.
27. Bergstein J, Kramer A, Wittman D, et al. Pseudomem-branous colitis: How useful is endoscopy? Surg Endosc 1990;4:217-219.
28. Kyne L, Merry C, O'Connell B. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing 1999;28:107-113.
29. Poutanen S, Simor A. Clostridium difficile-associated diarrhea in adults. Can Med Assoc J 2004;171:51-58.
30. Flegel W, Muller F, Daubener W. Cytokine response by human monocytes to Clostridium difficile toxin a and b. Infect Immun 1991;59:3659-3666.
31. Kelly C. Immune response to Clostridium difficile infection. Eur J Gastroenterol Hepatol 1996;8:1048-1053.
32. Wilcox M, Howe R. Diarrhoea caused by Clostridium difficile: Response time for treatment with metronidazole and van-comycin. J Antimicrob Chemother 1995;36:673-679.
33. Cherry R, Portnoy D, Jabbari M, et al. Metronidazole: An alternate therapy for antibiotic-associated colitis. Gastro-enterology 1982;82:849-851.
34. Teasley D, Gerding D, Olson M. Prospective randomized trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhea and colitis. Lancet 1983;2:1043-1046.
35. Musher D, Aslam S, Logan N. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005;40:1586-1590.
36. Zar F, Bakkanagari S, Moorthi K, Davis M. A comparison of vancomycin and metronidazole for the treatment of Clos-tridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45:302-307.
37. Aslam S, Hamill RJ, Musher D. Treatment of Clostridium difficile-associated disease: Old therapies and new strategies. Lancet Infect Dis 2005;5:549-557.
38. Bolton R, Culshaw M. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut 1986;27: 1169-1172.
39. Hermsen J, Dobrescu C, Kudsk K. Clostridium difficile infection: A surgical disease in evolution. J Gastrointest Surg 2008;12:1512-1517.
40. Sailhamer E, Carson K, Chang Y, et al. Fulminant Clostridium difficile colitis: Pattern of care and predictors of mortality. Arch Surg 2009;144:433-439.
41. Koss K, Clark M, Sanders D, et al. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis 2005; 8:149-154.
42. Videla S, Vilaseca J, Guarner F. Polyethylene glycol lavage prevents inflammatory lesions induced by trinitrobenzene-sulfonic acid in the rat colon. Gastroenterology 1994;106: A790.
43. Wellmann W, Fink P, Benner F, Schmidt F. Endotoxaemia in active Crohn's disease: Treatment with whole gut irrigation and 5-aminosalicyclic acid. Gut 1986;27:814-820.
44. Alverdy J, Piano G. Whole gut washout for severe sepsis: Review of technique and preliminary results. Surgery 1997; 121:89-94.